Indian J Dermatol 2018 Mar-Apr;63(2):125-130
Department of Dermatology, Calcutta National Medical College, Kolkata, West Bengal, India.
Some cutaneous adverse drug reactions (CADRs) are severe life-threatening conditions due to multisystem involvements with a high morbidity and mortality rates ranging from 25 - 70% and require immediate medical care. But there are huge controversies regarding the management because large clinical trials are lacking. Most frequent discussion and division occur regarding the use of systemic corticosteroid as early intervention with corticosteroids controls inflammation. Read More